Kenvue Inc. (KVUE) - Total Liabilities
Based on the latest financial reports, Kenvue Inc. (KVUE) has total liabilities worth $16.61 Billion USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore KVUE year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Kenvue Inc. - Total Liabilities Trend (2020–2024)
This chart illustrates how Kenvue Inc.'s total liabilities have evolved over time, based on quarterly financial data. See KVUE free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Kenvue Inc. Competitors by Total Liabilities
The table below lists competitors of Kenvue Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SANDVIK AB SP.ADR
F:SVK
|
Germany | €81.89 Billion |
|
Transurban Group
AU:TCL
|
Australia | AU$25.55 Billion |
|
Gold Fields Limited
F:EDG
|
Germany | €6.55 Billion |
|
Teck Resources Limited
TO:TECK-B
|
Canada | CA$19.43 Billion |
|
Crown Castle
NYSE:CCI
|
USA | $33.15 Billion |
|
adidas AG
F:ADS
|
Germany | €14.11 Billion |
|
China Pacific Insurance Group Co Ltd
SHG:601601
|
China | CN¥2.76 Trillion |
|
Orix Corp Ads
F:OIXA
|
Germany | €13.45 Trillion |
Liability Composition Analysis (2020–2024)
This chart breaks down Kenvue Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Kenvue Inc. market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.98 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.56 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.61 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Kenvue Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Kenvue Inc. (2020–2024)
The table below shows the annual total liabilities of Kenvue Inc. from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $15.93 Billion | -4.25% |
| 2023-12-31 | $16.64 Billion | +126.52% |
| 2022-12-31 | $7.35 Billion | -2.44% |
| 2021-12-31 | $7.53 Billion | -30.41% |
| 2020-12-31 | $10.82 Billion | -- |
About Kenvue Inc.
Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, … Read more